Hui-Chi Huang Selected Research

angelicae sinensis extract (dang-gui)

10/2021

Angelica sinensis extract promotes neuronal survival by enhancing p38 MAPK-mediated hippocampal neurogenesis and dendritic growth in the chronic phase of transient global cerebral ischemia in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hui-Chi Huang Research Topics

Disease

10	Neoplasms (Cancer) 02/2022 - 06/2011
3	Inflammation (Inflammations) 03/2021 - 01/2012
3	Mitochondrial Diseases (Mitochondrial Disease) 01/2021 - 04/2014
2	Ischemic Stroke 10/2021 - 06/2019
2	Colitis 01/2021 - 01/2013
2	Stroke (Strokes) 06/2019 - 01/2019
2	Dementia (Dementias) 02/2019 - 04/2010
2	Hepatocellular Carcinoma (Hepatoma) 09/2018 - 06/2011
2	Necrosis 05/2017 - 08/2010
2	Atherosclerosis 04/2014 - 09/2011
1	Asthma (Bronchial Asthma) 07/2022
1	Brain Ischemia (Cerebral Ischemia) 10/2021
1	Cardiomegaly (Heart Hypertrophy) 03/2021
1	Heart Failure 03/2021
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2021
1	Carcinogenesis 01/2021
1	Colonic Neoplasms (Colon Cancer) 01/2021
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Pain (Aches) 03/2020
1	Alzheimer Disease (Alzheimer's Disease) 02/2019
1	Nasopharyngeal Carcinoma 01/2019
1	Vascular Diseases (Vascular Disease) 01/2019
1	Memory Disorders (Memory Loss) 11/2018
1	Neuroinflammatory Diseases 11/2018
1	Abscess 09/2016
1	Hemorrhage 09/2016
1	Deglutition Disorders (Dysphagia) 01/2016
1	Metabolic Diseases (Metabolic Disease) 05/2015
1	Body Weight (Weight, Body) 05/2015
1	Leukemia 04/2014
1	Hemolysis 04/2014
1	Prostatic Neoplasms (Prostate Cancer) 01/2014
1	Diabetes Complications 01/2014

Drug/Important Bio-Agent (IBA)

4	AntioxidantsIBA 01/2021 - 02/2012
3	Peptides (Polypeptides)IBA 02/2022 - 02/2019
2	Pharmaceutical PreparationsIBA 01/2021 - 01/2012
2	Caspase 3 (Caspase-3)IBA 01/2021 - 04/2014
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2021 - 01/2019
2	Free RadicalsIBA 01/2015 - 09/2011
1	Hypoglycemic Agents (Hypoglycemics)IBA 07/2022
1	p38 Mitogen-Activated Protein KinasesIBA 10/2021
1	angelicae sinensis extract (dang-gui)IBA 10/2021
1	Sodium Lactate FDA LinkGeneric 03/2021
1	Lactic Acid (Lactate)FDA LinkGeneric 03/2021
1	bryophyllin AIBA 01/2021
1	thiazolyl blueIBA 01/2021
1	AzoxymethaneIBA 01/2021
1	BufanolidesIBA 01/2021
1	Dextrans (Dextran)FDA Link 01/2021
1	SodiumIBA 01/2021
1	Rutin (Rutoside)IBA 01/2020
1	Combined VaccinesIBA 01/2020
1	VaccinesIBA 01/2020
1	Cytochrome P-450 CYP2C19IBA 06/2019
1	Clopidogrel (Plavix)FDA Link 06/2019
1	GlycosidesIBA 02/2019
1	Amyloid (Amyloid Fibrils)IBA 02/2019
1	Prescription DrugsIBA 02/2019
1	Scopolamine (Hyoscine)FDA Link 11/2018
1	Cholinergic Agents (Cholinergics)IBA 11/2018
1	indirubinIBA 11/2018
1	ficusalIBA 09/2018
1	p-coumaric acidIBA 09/2018
1	balanophoninIBA 09/2018
1	Acetylcysteine (Siran)FDA LinkGeneric 05/2017
1	Annexin A5IBA 05/2017
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 05/2015
1	AdiponectinIBA 05/2015
1	Carotenoids (Carotene)IBA 05/2015
1	Triglycerides (Triacylglycerol)IBA 05/2015
1	CholesterolIBA 05/2015
1	LycopeneIBA 05/2015
1	PhytochemicalsIBA 05/2015
1	LipopolysaccharidesIBA 01/2015
1	Cyclin D1IBA 04/2014
1	Retinoblastoma ProteinIBA 04/2014
1	Fas Ligand Protein (Fas Ligand)IBA 04/2014
1	Cyclin EIBA 04/2014
1	Cytochromes c (Cytochrome c)IBA 04/2014
1	Cyclin AIBA 04/2014
1	Cell Cycle ProteinsIBA 04/2014
1	LDL Lipoproteins (beta Lipoproteins)IBA 04/2014
1	2,2'-azobis(2-amidinopropane) (ABAP)IBA 04/2014
1	phenanthreneIBA 01/2014
1	denbinobinIBA 01/2014
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2014
1	Insulin (Novolin)FDA Link 01/2014
1	Insulin ReceptorIBA 01/2014
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 01/2014
1	ginger extractIBA 01/2013
1	zingeroneIBA 01/2013
1	Therapeutic UsesIBA 01/2013
1	sym-trinitrobenzeneIBA 01/2013

Therapy/Procedure

2	Oral Administration 03/2020 - 01/2019
1	Secondary Prevention 06/2019
1	Subacute Care 01/2019
1	Therapeutics 01/2019
1	Traditional Medicine (Folk Remedies) 09/2016
1	Long-Term Care 01/2016
1	Glycemic Control 01/2014